Case ReportJournal of Pharmacy Practice and Community MedicineVol. 12 | Issue 3 | 2026 | pp. 176–179Open access
A Case Report on Decompensated Chronic Liver Disease with Budd–Chiari Syndrome
- 1,
- 1,
- 1*,
- 1,
- 1,
- 1,
- 1,
- 1,
- 1,
- 1
- 1 Department of Pharmacology and Pharmacy Practice, Nirmala College of Pharmacy, Atmakuru, Mangalagiri, Guntur, Andhra Pradesh, INDIA.
Published in Journal of Pharmacy Practice and Community Medicine
Correspondence: Padigala Ramya Jyothi
Department of Pharmacology and Pharmacy Practice, Nirmala College of Pharmacy, Atmakuru, Mangalagiri, Guntur, Andhra Pradesh, INDIA.
Email: padigalaramya5@gmail.com
Copyright: © 2026 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2026
- DOI:
- 10.5530/jppcm.20260020
How to cite
Maharshi, M., Thaneti, J. N., Jyothi, P. R., Devi, A. G. N. H., Deepa, N., Hemalatha, G., Kedareswari, J., Paul, N. E. M., Sathwika, M. H., & Jirra, V. B. (2026). A Case Report on Decompensated Chronic Liver Disease with Budd–Chiari Syndrome. Journal of Pharmacy Practice and Community Medicine, 12(3), 176–179. https://doi.org/10.5530/jppcm.20260020
Abstract
The rare illness, known as Budd-Chiari Syndrome (BCS), is characterized by hepatic venous outflow tract obstruction and can arise from the right atrium, inferior vena cava, or the tiny hepatic veins within the liver. It is an uncommon liver condition in which obstructions, typically caused by blood clots, restrict the hepatic veins, preventing blood from exiting the liver and returning to the heart. As a result, the liver enlarges (hepatomegaly), accumulates fluid (ascites), and causes abdominal pain. We present a rare case of a young female diagnosed with decompensated chronic liver disease secondary to Budd–Chiari syndrome, who came with the features of abdominal distension and weight loss, along with a Model for end stage liver disease Na score of 20 and splenomegaly with portal hypertension. The diagnosis was confirmed by Doppler ultrasonography and contrast-enhanced CT of the abdomen, supported by abnormal laboratory parameters including prolonged prothrombin time with elevated INR, decreased serum albumin and total protein levels, and elevated WBC count, lymphocytes, GGT, and bilirubin. Management included anticoagulants, antibiotics, statins, proton pump inhibitors, β blockers, hepatoprotective agents, diuretics, and other supportive care, with a step-up approach planned for hepatic venous outflow restoration to prevent disease progression.
Keywords
Subject
Article metadata
| Title | A Case Report on Decompensated Chronic Liver Disease with Budd–Chiari Syndrome |
|---|---|
| Authors | Mallela Maharshi; Joel Nathan Thaneti; Padigala Ramya Jyothi; A. G. N. Harshita Devi; Nani Deepa; Ganjala Hemalatha; Jonnadula Kedareswari; Nemalikanti Elizabeth Mary Paul; Manchikanti Hima Sathwika; Vijaya Bhaskar Jirra |
| Affiliations | Department of Pharmacology and Pharmacy Practice, Nirmala College of Pharmacy, Atmakuru, Mangalagiri, Guntur, Andhra Pradesh, INDIA. |
| Corresponding author | padigalaramya5@gmail.com |
| Journal | Journal of Pharmacy Practice and Community Medicine |
| Volume / Issue | Vol. 12, Issue 3 (2026) |
Also in this issue
- A Translational Investigation Linking Pharmacological Mechanisms of Drug Toxicity to Clinical Safety Outcomes and Adverse Drug Reactionspp. 128–137
- Awareness, Attitudes, and Practices of Infection Control in Libya: A Mixed-Methods Studypp. 138–141
- Quality Improvement through NABH Accreditation: A Review of Strategies for Preventing Medication Errors in Hospitalspp. 142–147
- Psychotherapeutic Interventions for Anxiety Disorders: A Narrative Review of Mechanisms, Efficacy, and Implementation Barrierspp. 148–154
- Nanotechnology-Based Drug Delivery in Cancer and Neurological Disorderspp. 155–163